PFIZER Awarded $5.3 Billion Army Contract
Copyright © Targeted News Service 2021
2021-11-27
WASHINGTON, Nov. 27 -- The U.S. Army Contracting Command issued the following high-value contract information through the Pentagon on Nov. 18, 2021:
PFIZER, New York, was awarded a $5,295,000,000 firm-fixed-price contract (W58P05-22-C-0001) for 10 million doses of Pfizer's oral protease inhibitor drug (PF-07321332).
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity.(Awarded Nov. 17, 2021)[DODBT] . . .
PFIZER, New York, was awarded a $5,295,000,000 firm-fixed-price contract (W58P05-22-C-0001) for 10 million doses of Pfizer's oral protease inhibitor drug (PF-07321332).
The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity.(Awarded Nov. 17, 2021)[DODBT] . . .
